Blood Cancer
Know your options
A diagnosis of blood cancer may be life changing for you, your family and friends.
Getting the facts about your diagnosis and available treatments will help you make the best decision based on your situation. It is important to tell your doctor and nurse how you prefer to receive information and how much you want to know.
Don’t be afraid to voice your questions and concerns as this will help you and your health care team form a partnership in your care.
For further information you can also visit Leukaemia and Blood Cancer New Zealand website.
Roche offers several medications for blood cancer that have shown effective results in clinical trials. One of them may be a suitable treatment option for you.
Roche blood cancer treatments available in New Zealand
Gazyva® (obinutuzumab)
Gazyva is a monoclonal antibody therapy, used for the treatment of indolent non-Hodgkin’s lymphoma (iNHL), follicular lymphoma (FL) and chronic lymphocytic leukaemia (CLL).
Polivy® (polatuzumab vedotin)
Polivy® (polatuzumab vedotin)
is an anti-cancer agent. It is used to treat a type of blood cancer called diffuse large B-cell lymphoma (DLBCL).